Myriad Genetics Inc. MYGN shares plunged 37.80% in Thursday’s after-hours session after the company reported second-quarter ...

Myriad Genetics partners with AWS to enhance Image Genius, speeding up document processing, and improving insurance workflows ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 46.1% in the afternoon session after the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Myriad Genetics lowered its full-year revenue guidance, as second quarter sales fell due to volume challenges in prenatal health and increased payer friction. The genetic testing and precision ...

Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is engaging ...

Deep learning approaches have transformed how scientists predict the activity and function of DNA sequences in the genome. A ...

View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Good day, and thank you for standing by. Welcome to Myriad Genetics' Second Quarter 2026 Financial Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...

Researchers have identified the first evidence of genetic risk factors associated with borderline personality disorder (BPD).

Highlights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is en ...